Shares of Herbalife Ltd. (NYSE:HLF) have received a consensus rating of “Hold” from the six ratings firms that are currently covering the stock. Five equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $67.43.

Several equities research analysts recently commented on the stock. Zacks Investment Research lowered shares of Herbalife from a “buy” rating to a “hold” rating in a research note on Wednesday, September 21st. Pivotal Research reissued a “buy” rating and set a $90.00 price objective on shares of Herbalife in a research report on Wednesday, October 26th. TheStreet downgraded shares of Herbalife from a “buy” rating to a “hold” rating in a research report on Tuesday, August 9th. Finally, SunTrust Banks Inc. reissued a “neutral” rating and set a $66.00 price objective on shares of Herbalife in a research report on Friday, August 5th.

Shares of Herbalife (NYSE:HLF) opened at 50.87 on Tuesday. The stock’s 50 day moving average is $57.95 and its 200-day moving average is $60.98. The stock has a market capitalization of $4.73 billion, a price-to-earnings ratio of 17.86 and a beta of 1.87. Herbalife has a one year low of $42.26 and a one year high of $72.22.

Herbalife (NYSE:HLF) last announced its quarterly earnings results on Tuesday, November 1st. The company reported $1.21 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.09 by $0.12. Herbalife had a net margin of 5.40% and a return on equity of 1,018.52%. The firm had revenue of $1.12 billion for the quarter, compared to analyst estimates of $18.70 million. During the same period last year, the business earned $1.28 EPS. Herbalife’s revenue for the quarter was up 1.7% compared to the same quarter last year. On average, equities research analysts predict that Herbalife will post $4.85 EPS for the current fiscal year.

In other news, major shareholder Carl C. Icahn bought 1,056,069 shares of the stock in a transaction dated Tuesday, November 8th. The shares were acquired at an average price of $55.05 per share, with a total value of $58,136,598.45. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Carl C. Icahn bought 306,846 shares of the stock in a transaction dated Wednesday, August 31st. The stock was purchased at an average cost of $60.39 per share, for a total transaction of $18,530,429.94. The disclosure for this purchase can be found here. 4.91% of the stock is currently owned by insiders.

Hedge funds have recently modified their holdings of the stock. Phocas Financial Corp. increased its stake in shares of Herbalife by 39.2% in the third quarter. Phocas Financial Corp. now owns 51,359 shares of the company’s stock valued at $3,184,000 after buying an additional 14,463 shares during the last quarter. Verition Fund Management LLC increased its stake in Herbalife by 434.2% in the third quarter. Verition Fund Management LLC now owns 28,753 shares of the company’s stock worth $1,782,000 after buying an additional 23,371 shares in the last quarter. Gerstein Fisher increased its stake in Herbalife by 1.1% in the third quarter. Gerstein Fisher now owns 43,493 shares of the company’s stock worth $2,696,000 after buying an additional 471 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Herbalife during the third quarter worth approximately $945,000. Finally, Panagora Asset Management Inc. increased its stake in Herbalife by 18.4% in the third quarter. Panagora Asset Management Inc. now owns 118,661 shares of the company’s stock worth $7,356,000 after buying an additional 18,400 shares in the last quarter.

COPYRIGHT VIOLATION WARNING: This piece of content was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was stolen and reposted in violation of US & international copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/25/brokerages-set-herbalife-ltd-hlf-target-price-at-67-43.html.

Herbalife Company Profile

Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. The Company’s segments include North America; Mexico; South & Central America; Europe, Middle East, and Africa (EMEA); Asia Pacific, and China.

5 Day Chart for NYSE:HLF

Receive News & Stock Ratings for Herbalife Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Ltd. and related stocks with our FREE daily email newsletter.